Extended release formulation of venlafaxine

Details Extended release formulation of venlafaxine Extended release formulation of venlafaxine

A - Human Necessities

61

K

A61K 31/137 (2006.01) A61K 9/16 (2006.01) A61K 9/50 (2006.01) A61K 9/62 (2006.01) A61P 25/24 (2006.01)

Patent

CA 2199778

This invention relates to a 24 hour extended release dosage formulation and unit dosage form thereof of venlafaxine hydrochloride, an antidepressant, which provides better control of blood plasma levels than conventional tablet formulations which must be administered two or more times a day and further provides a lower incidence of nausea and vomiting than the conventional tablets.

Affiliated with

Also associated with

Rating

Extended release formulation of venlafaxine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Extended release formulation of venlafaxine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Extended release formulation of venlafaxine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1783785